Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children
Clinical trial NCT01323946 · COMPLETED
Trial details
- NCT number
- NCT01323946
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-18
- Primary completion
- 2012-06-22
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.